Health‐related quality of life in multiple sclerosis: effects of natalizumab

Richard A. Rudick, Deborah Miller, Steven Hass, Michael Hutchinson, Peter A. Calabresi, Christian Confavreux, Steven Galetta, Gavin Giovannoni, Eva Havrdová, Ludwig Kappos, Fred Lublin, David H. Miller, Paul O’Connor, J. Theodore Phillips, Chris H. Polman, Ernst‐Wilhelm Radue, William H. Stuart, A Wajgt, Bianca Weinstock‐Guttman, Daniel Wynn, Frances Lynn, Michael PanzaraAnnals 2007 · DOI

Abstract

HRQoL was impaired in relapsing multiple sclerosis patients, correlated with severity of disease as measured by neurological ratings or magnetic resonance imaging, and improved significantly with natalizumab.
BibTeX
@article{rudick2007healthrelated,
  author = {Richard A. Rudick and Deborah Miller and Steven Hass and Michael Hutchinson and Peter A. Calabresi and Christian Confavreux and Steven Galetta and Gavin Giovannoni and Eva Havrdová and Ludwig Kappos and Fred Lublin and David H. Miller and Paul O’Connor and J. Theodore Phillips and Chris H. Polman and Ernst‐Wilhelm Radue and William H. Stuart and A Wajgt and Bianca Weinstock‐Guttman and Daniel Wynn and Frances Lynn and Michael Panzara},
  title = {{Health‐related quality of life in multiple sclerosis: effects of natalizumab}},
  journal = {Annals},
  year = {2007},
  doi = {10.1002/ana.21163},
}

Loading related content...

Figure